February 27, 2019 -- VIENNA - Screening of breast cancer with abbreviated MRI is now viable, cost-effective, and ready for clinical use, according to Dr. Christiane Kuhl of Aachen University Hospital in Germany. Being one of only two female heads of radiology at university hospitals in the country, she also speaks about whether there is a glass ceiling in medical imaging and gives practical and timely advice on how to conduct better research.